{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:07:45Z","timestamp":1794377265137,"version":"4.9.0"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005739","name":"Universidad Nacional Aut\u00c3\u00b3noma de M\u00c3\u00a9xico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013395","name":"Sistema Nacional de Investigadores","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00c3\u00ada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006087","name":"Direcci\u00c3\u00b3n General de Asuntos del Personal Acad\u00c3\u00a9mico, Universidad Nacional Aut\u00c3\u00b3noma de M\u00c3\u00a9xico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.prostaglandins.2020.106451","type":"journal-article","created":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T17:58:31Z","timestamp":1586714311000},"page":"106451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Role of epoxyeicosatrienoic acids in the lung"],"prefix":"10.1016","volume":"149","author":[{"given":"Hugo F.","family":"Olivares-Rubio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Espinosa-Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/03602532.2018.1439502","article-title":"Cytochrome P450 in the central nervous system as a therapeutic target in neurodegenerative diseases","volume":"50","author":"Navarro-Mabarak","year":"2018","journal-title":"Drug metabolism reviews"},{"issue":"39","key":"10.1016\/j.prostaglandins.2020.106451_bib0010","doi-asserted-by":"crossref","first-page":"36059","DOI":"10.1074\/jbc.R100030200","article-title":"Epoxygenase pathways of arachidonic acid metabolism","volume":"276","author":"Zeldin","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0015","series-title":"Cytochrome P450, P450 Enzymes in Lipid Oxidation","first-page":"881","author":"Edin","year":"2015"},{"issue":"Supplement","key":"10.1016\/j.prostaglandins.2020.106451_bib0020","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1194\/jlr.R800038-JLR200","article-title":"Arachidonic acid cytochrome P450 epoxygenase pathway","volume":"50","author":"Spector","year":"2009","journal-title":"Journal of lipid research"},{"issue":"15","key":"10.1016\/j.prostaglandins.2020.106451_bib0025","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1007\/s00018-015-1960-9","article-title":"The lung communication network","volume":"72","author":"Losa","year":"2015","journal-title":"Cellular and molecular life sciences"},{"issue":"11","key":"10.1016\/j.prostaglandins.2020.106451_bib0030","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1383\/anes.2005.6.11.370","article-title":"Fluid balance and non-respiratory functions of the lung","volume":"6","author":"Campbell","year":"2005","journal-title":"Anaesthesia & Intensive Care Medicine"},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106451_bib0035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/1389200023337054","article-title":"The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans","volume":"3","author":"Danielson","year":"2002","journal-title":"Current drug metabolism"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106451_bib0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/tx700079z","article-title":"Cytochrome p450 and chemical toxicology","volume":"21","author":"Guengerich","year":"2007","journal-title":"Chemical research in toxicology"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0045","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2147\/DDDT.S149069","article-title":"The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo","volume":"12","author":"Sychev","year":"2018","journal-title":"Drug design, development and therapy"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106451_bib0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0006-2952(92)90055-N","article-title":"Detection of human lung cytochrome P450 that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIA","volume":"44","author":"Wheeler","year":"1992","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0055","first-page":"4608","article-title":"Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues","volume":"53","author":"Toussaint","year":"1993","journal-title":"Lung cancer"},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106451_bib0060","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1021\/tx00042a026","article-title":"Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450","volume":"7","author":"Nakajima","year":"1994","journal-title":"Chemical Research in Toxicology"},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106451_bib0065","first-page":"515","article-title":"Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal livers and adult lungs","volume":"24","author":"Shimada","year":"1996","journal-title":"Drug Metabolism and Disposition"},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106451_bib0070","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0959-8049(98)00034-3","article-title":"Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissue","volume":"34","author":"Mac\u00e9","year":"1998","journal-title":"European Journal of Cancer"},{"issue":"9208","key":"10.1016\/j.prostaglandins.2020.106451_bib0075","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(00)99016-0","article-title":"Gene expression in distinct regions of the heart","volume":"355","author":"Thum","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106451_bib0080","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0026-895X(25)09539-2","article-title":"CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance","volume":"50","author":"Zeldin","year":"1996","journal-title":"Molecular pharmacology"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0085","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0003-9861(95)90023-3","article-title":"Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes","volume":"320","author":"Rifkind","year":"1995","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0090","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/46816","article-title":"Cytochrome P450 2C is an EDHF synthase in coronary arteries","volume":"401","author":"Fisslthaler","year":"1999","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106451_bib0095","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/20024091064273","article-title":"Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung","volume":"32","author":"Hukkanen","year":"2002","journal-title":"Critical reviews in toxicology"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106451_bib0100","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.2001.280.1.H1","article-title":"The lung HETEs (and EETs) up","volume":"280","author":"Jacobs","year":"2001","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106451_bib0105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tcm.2007.11.002","article-title":"Vascular cytochrome p450 enzymes: physiology and pathophysiology","volume":"18","author":"Fleming","year":"2008","journal-title":"Trends in cardiovascular medicine"},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106451_bib0110","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1152\/japplphysiol.00120.2017","article-title":"The endothelium in hypoxic pulmonary vasoconstriction","volume":"123","author":"Grimmer","year":"2017","journal-title":"Journal of Applied Physiology"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0115","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/FJC.0b013e3181ed088d","article-title":"Cytochrome P450-derived epoxyeicosatrienoic acids and pulmonary hypertension: central role of transient receptor potential C6 channels","volume":"57","author":"Loot","year":"2011","journal-title":"Journal of cardiovascular pharmacology"},{"issue":"3-4","key":"10.1016\/j.prostaglandins.2020.106451_bib0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.prostaglandins.2012.09.006","article-title":"Beneficial effects of n-3 PUFA on chronic airway inflammatory diseases","volume":"99","author":"Giudetti","year":"2012","journal-title":"Prostaglandins & other lipid mediators"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0125","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti- inflammatory properties of cytochrome P450 expoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"issue":"33","key":"10.1016\/j.prostaglandins.2020.106451_bib0130","doi-asserted-by":"crossref","first-page":"13528","DOI":"10.1073\/pnas.1311565110","article-title":"Epoxyeicosanoids promote organ and tissue regeneration","volume":"110","author":"Panigrahy","year":"2013","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0135","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pharmthera.2017.06.006","article-title":"Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases","volume":"180","author":"Wagner","year":"2017","journal-title":"Pharmacology & therapeutics"},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106451_bib0140","first-page":"661","article-title":"Functional role of epoxyeicosatrienoic acids and their production in astrocytes: approaches for gene transfer and therapy","volume":"2","author":"Medhora","year":"1998","journal-title":"International journal of molecular medicine"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.prostaglandins.2018.07.002","article-title":"Neuroprotective Effects of Epoxyeicosatrienoic Acids","volume":"138","author":"Wang","year":"2018","journal-title":"Prostaglandins & other lipid mediators"},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106451_bib0150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2362.2006.01634.x","article-title":"Emerging role of epoxyeicosatrienoic acids in coronary vascular function","volume":"36","author":"Larsen","year":"2006","journal-title":"European journal of clinical investigation"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yjmcc.2014.05.016","article-title":"Epoxyeicosatrienoic acids and cardioprotection: the road to translation","volume":"74","author":"Oni-Orisan","year":"2014","journal-title":"Journal of molecular and cellular cardiology"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0160","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fphar.2014.00239","article-title":"Inside epoxyeicosatrienoic acids and cardiovascular disease","volume":"5","author":"Tacconelli","year":"2014","journal-title":"Frontiers in pharmacology"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106451_bib0165","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/bcp.12603","article-title":"The role of epoxyeicosatrienoic acids in the cardiovascular system","volume":"80","author":"Yang","year":"2015","journal-title":"British journal of clinical pharmacology"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pharmthera.2017.05.005","article-title":"Cytochrome P450-derived eicosanoids and heart function","volume":"179","author":"Jamieson","year":"2017","journal-title":"Pharmacology & therapeutics"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0175","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.prostaglandins.2016.05.004","article-title":"EETs\/sEH in diabetes and obesity-induced cardiovascular diseases","volume":"125","author":"Huang","year":"2016","journal-title":"Prostaglandins & other lipid mediators"},{"issue":"11","key":"10.1016\/j.prostaglandins.2020.106451_bib0180","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.tips.2016.08.001","article-title":"Epoxyeicosatrienoic acid as therapy for diabetic and ischemic cardiomyopathy","volume":"37","author":"Romashko","year":"2016","journal-title":"Trends in pharmacological sciences"},{"issue":"7","key":"10.1016\/j.prostaglandins.2020.106451_bib0185","doi-asserted-by":"crossref","first-page":"E1916","DOI":"10.3390\/ijms19071916","article-title":"Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes","volume":"19","author":"Aliwarga","year":"2018","journal-title":"International journal of molecular sciences"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0190","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1471-4892(03)00015-8","article-title":"HETEs\/EETs in renal glomerular and epithelial cell functions","volume":"3","author":"Natarajan","year":"2003","journal-title":"Current opinion in pharmacology"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.prostaglandins.2013.01.002","article-title":"Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function","volume":"104","author":"Imig","year":"2013","journal-title":"Prostaglandins & other lipid mediators"},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106451_bib0200","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/HYPERTENSIONAHA.114.03585","article-title":"Epoxyeicosatrienoic acids, hypertension, and kidney injury","volume":"65","author":"Imig","year":"2015","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.prostaglandins.2020.106451_bib0205","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1681\/ASN.2017030252","article-title":"Effect of cytochrome P450 metabolites of arachidonic acid in nephrology","volume":"28","author":"Fan","year":"2017","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106451_bib0210","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/1753-0407.12358","article-title":"Soluble epoxide hydrolase: A potential target for metabolic diseases: \u53ef\u6eb6\u6027\u8868\u6c27\u5316\u7269\u9176: \u4ee3\u8c22\u6027\u75be\u75c5\u7684\u6f5c\u5728\u6cbb\u7597\u9776\u70b9","volume":"8","author":"He","year":"2016","journal-title":"Journal of diabetes"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0215","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.prostaglandins.2016.07.010","article-title":"Epoxyeicosatrienoic acids and glucose homeostasis in mice and men","volume":"125","author":"Luther","year":"2016","journal-title":"Prostaglandins & other lipid mediators"},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106451_bib0220","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3945\/an.116.012245","article-title":"The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic Diseases","volume":"7","author":"Xu","year":"2016","journal-title":"Advances in Nutrition"},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106451_bib0225","doi-asserted-by":"crossref","first-page":"H1355","DOI":"10.1152\/ajpheart.1996.270.4.H1355","article-title":"Inhibition of cytochrome P-450 attenuates hypoxemia of acute lung injury in dogs","volume":"270","author":"Stephenson","year":"1996","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106451_bib0230","doi-asserted-by":"crossref","first-page":"L423","DOI":"10.1152\/ajplung.1998.275.3.L423","article-title":"Epoxyeicosatrienoic acids relax airway smooth muscles and directly activate reconstituted KCa channels","volume":"275","author":"Dumoulin","year":"1998","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0235","doi-asserted-by":"crossref","first-page":"L335","DOI":"10.1152\/ajplung.2000.278.2.L335","article-title":"Epoxyeicosatrienoic acids constrict isolated pressurized rabbit pulmonary arteries","volume":"278","author":"Zhu","year":"2000","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106451_bib0240","doi-asserted-by":"crossref","first-page":"L965","DOI":"10.1152\/ajplung.2001.280.5.L965","article-title":"EETs relax airway smooth muscle via an EpDHF effect: BKCa channel activation and hyperpolarization","volume":"280","author":"Benoit","year":"2001","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"1-4","key":"10.1016\/j.prostaglandins.2020.106451_bib0245","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.prostaglandins.2006.05.012","article-title":"Effects of 5-oxo-ETE and 14, 15-EET on reactivity and Ca2+ sensitivity in guinea pig bronchi","volume":"82","author":"Morin","year":"2007","journal-title":"Prostaglandins & other lipid mediators"},{"issue":"12","key":"10.1016\/j.prostaglandins.2020.106451_bib0250","doi-asserted-by":"crossref","first-page":"L1478","DOI":"10.1152\/ajplung.00208.2015","article-title":"EET-dependent potentiation of pulmonary arterial pressure: sex-different regulation of soluble epoxide hydrolase","volume":"309","author":"Kandhi","year":"2015","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106451_bib0255","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1165\/rcmb.2006-0281OC","article-title":"Epoxyeicosatrienoic acid relaxing effects involve Ca2+-activated K+ channel activation and CPI-17 dephosphorylation in human bronchi","volume":"36","author":"Morin","year":"2007","journal-title":"American journal of respiratory cell and molecular biology"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0260","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1165\/rcmb.2007-0232OC","article-title":"EET Displays Anti-Inflammatory Effects in TNF-\u03b1\u2013Stimulated Human Bronchi: Putative Role of CPI-17","volume":"38","author":"Morin","year":"2008","journal-title":"American journal of respiratory cell and molecular biology"},{"issue":"8","key":"10.1016\/j.prostaglandins.2020.106451_bib0265","doi-asserted-by":"crossref","first-page":"L562","DOI":"10.1152\/ajplung.00379.2012","article-title":"Relationship between bradykinin-induced relaxation and endogenous epoxyeicosanoid synthesis in human bronchi","volume":"304","author":"Tabet","year":"2013","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106451_bib0270","doi-asserted-by":"crossref","first-page":"L675","DOI":"10.1152\/ajplung.00427.2010","article-title":"Improved bioavailability of epoxyeicosatrienoic acids reduces TP-receptor agonist-induced tension in human bronchi","volume":"301","author":"Senouvo","year":"2011","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"9","key":"10.1016\/j.prostaglandins.2020.106451_bib0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046065","article-title":"11, 12-EET stimulates the association of BK channel \u03b1 and \u03b21 subunits in mitochondria to induce pulmonary vasoconstriction","volume":"7","author":"Loot","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.prostaglandins.2020.106451_bib0280","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1172\/JCI59176","article-title":"Hypoxic pulmonary vasoconstriction requires connexin 40\u2013mediated endothelial signal conduction","volume":"122","author":"Wang","year":"2012","journal-title":"The Journal of clinical investigation"},{"issue":"11","key":"10.1016\/j.prostaglandins.2020.106451_bib0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003950","article-title":"Deletion of the murine cytochrome P450 Cyp2j locus by fused BAC-mediated recombination identifies a role for Cyp2j in the pulmonary vascular response to hypoxia","volume":"9","author":"Zhou","year":"2013","journal-title":"PLoS genetics"},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106451_bib0290","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/01.HYP.0000208299.62535.58","article-title":"Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling","volume":"47","author":"Pokreisz","year":"2006","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0295","doi-asserted-by":"crossref","first-page":"L350","DOI":"10.1152\/ajplung.00038.2017","article-title":"EETs promote hypoxic pulmonary vasoconstriction via constrictor prostanoids","volume":"313","author":"Kandhi","year":"2017","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106451_bib0300","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12871-018-0490-z","article-title":"Deletion of soluble epoxide hydrolase attenuates mice Hyperoxic acute lung injury","volume":"18","author":"Liu","year":"2018","journal-title":"BMC anesthesiology"},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106451_bib0305","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jaci.2012.04.023","article-title":"Epoxyeicosatrienoic acids are involved in the C70 fullerene derivative\u2013induced control of allergic asthma","volume":"130","author":"Norton","year":"2012","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106451_bib0310","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s10753-018-0758-y","article-title":"Effect of Soluble Epoxide Hydrolase in Hyperoxic Acute Lung Injury in Mice","volume":"41","author":"Li","year":"2018","journal-title":"Inflammation"},{"issue":"Suppl. 2","key":"10.1016\/j.prostaglandins.2020.106451_bib0315","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13223-018-0279-0","article-title":"Asthma","volume":"14","author":"Quirt","year":"2018","journal-title":"Allergy, Asthma, and Clinical Immunology"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106451_bib0320","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/cc1451","article-title":"Clinical review: severe asthma","volume":"6","author":"Papiris","year":"2001","journal-title":"Critical Care"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0325","doi-asserted-by":"crossref","first-page":"AB365","DOI":"10.1016\/j.jaci.2012.01.008","article-title":"Discovery Of A New Mechanism To Control Allergic Asthma Using Fullerene C70 Derivatives","volume":"129","author":"Kepley","year":"2012","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0330","series-title":"Fullerene C70 derivatives dampen anaphylaxis and allergic asthma pathogenesis in mice, Norton S, Theses and Dissertations, Virginia Commonwealth","year":"2012"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106451_bib0335","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1165\/rcmb.2013-0440OC","article-title":"Soluble epoxide hydrolase inhibitor attenuates inflammation and airway hyperresponsiveness in mice","volume":"52","author":"Yang","year":"2015","journal-title":"American journal of respiratory cell and molecular biology"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106451_bib0340","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1378\/chest.07-0371","article-title":"Promoter polymorphism G-50T of a human CYP2J2 epoxygenase gene is associated with common susceptibility to asthma","volume":"132","author":"Polonikov","year":"2007","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106451_bib0345","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1109\/JSEN.2009.2035736","article-title":"Endogenous levels of five fatty acid metabolites in exhaled breath condensate to monitor asthma by high-performance liquid chromatography: electrospray tandem mass spectrometry","volume":"10","author":"Nording","year":"2010","journal-title":"IEEE sensors journal"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0350","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/6\/2\/026001","article-title":"Profile of eicosanoids in breath condensate in asthma and COPD","volume":"6","author":"Fritscher","year":"2012","journal-title":"Journal of breath research"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0355","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1139\/y11-117","article-title":"Bronchial inflammation induced PKC\u03b6 over-expression: involvement in mechanical properties of airway smooth muscle","volume":"90","author":"Morin","year":"2012","journal-title":"Canadian journal of physiology and pharmacology"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0360","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.prostaglandins.2013.05.001","article-title":"Eicosanoid biosynthesis during mucociliary and mucous metaplastic differentiation of bronchial epithelial cells","volume":"106","author":"Jakiela","year":"2013","journal-title":"Prostaglandins & other lipid mediators"},{"issue":"8","key":"10.1016\/j.prostaglandins.2020.106451_bib0365","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1164\/rccm.201403-0544OC","article-title":"Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma","volume":"190","author":"Ono","year":"2014","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106451_bib0370","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jaci.2016.09.031","article-title":"Dysregulation of lipidomic profile and antiviral immunity in response to hyaluronan in patients with severe asthma","volume":"139","author":"Sokolowska","year":"2017","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106451_bib0375","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5858\/arpa.2015-0519-RA","article-title":"Acute lung injury: a clinical and molecular review","volume":"140","author":"Butt","year":"2016","journal-title":"Archives of Pathology and Laboratory Medicine"},{"issue":"9","key":"10.1016\/j.prostaglandins.2020.106451_bib0380","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2169\/internalmedicine.48.1741","article-title":"Acute lung injury review","volume":"48","author":"Tsushima","year":"2009","journal-title":"Internal medicine"},{"issue":"9","key":"10.1016\/j.prostaglandins.2020.106451_bib0385","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000247065.11756.19","article-title":"Transient receptor potential vanilloid 4\u2013mediated disruption of the alveolar septal barrier: a novel mechanism of acute lung injury","volume":"99","author":"Alvarez","year":"2006","journal-title":"Circulation research"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0390","doi-asserted-by":"crossref","first-page":"L445","DOI":"10.1152\/ajplung.00150.2003","article-title":"Role of EETs in regulation of endothelial permeability in rat lung","volume":"286","author":"Alvarez","year":"2004","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106451_bib0395","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1165\/rcmb.2007-0192OC","article-title":"High vascular pressure\u2013induced lung injury requires P450 epoxygenase\u2013dependent activation of TRPV4","volume":"38","author":"Jian","year":"2008","journal-title":"American journal of respiratory cell and molecular biology"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0400","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1549-8719.2009.00013.x","article-title":"Impact of epoxyeicosatrienoic acids in lung ischemia\u2013reperfusion injury","volume":"17","author":"Townsley","year":"2010","journal-title":"Microcirculation"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0405","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/680166","article-title":"Functional coupling of TRPV4, IK, and SK channels contributes to Ca2+-dependent endothelial injury in rodent lung","volume":"5","author":"Lin","year":"2015","journal-title":"Pulmonary circulation"},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106451_bib0410","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1165\/rcmb.2014-0225OC","article-title":"Role of transient receptor potential vanilloid 4 in neutrophil activation and acute lung injury","volume":"54","author":"Yin","year":"2016","journal-title":"American journal of respiratory cell and molecular biology"},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106451_bib0415","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1159\/000374011","article-title":"CYP2J2 and EETs protect against lung ischemia\/reperfusion injury via anti-inflammatory effects in vivo and in vitro","volume":"35","author":"Chen","year":"2015","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"8","key":"10.1016\/j.prostaglandins.2020.106451_bib0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160359","article-title":"Effects of a soluble epoxide hydrolase inhibitor on lipopolysaccharide-induced acute lung injury in mice","volume":"11","author":"Tao","year":"2016","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106451_bib0425","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/SHK.0000000000000767","article-title":"Soluble epoxide hydrolase inhibitor attenuates lipopolysaccharide-induced acute lung injury and improves survival in mice","volume":"47","author":"Zhou","year":"2017","journal-title":"Shock"},{"issue":"7","key":"10.1016\/j.prostaglandins.2020.106451_bib0430","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3390\/nu10070813","article-title":"Potential micronutrients and phytochemicals against the pathogenesis of chronic obstructive pulmonary disease and lung cancer","volume":"10","author":"Zhai","year":"2018","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.prostaglandins.2020.106451_bib0435","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1470-2045(02)00815-X","article-title":"Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention","volume":"3","author":"Hecht","year":"2002","journal-title":"The lancet oncology"},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106451_bib0440","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1183\/09031936.03.00040703","article-title":"Chronic obstructive pulmonary disease: molecular and cellular mechanisms","volume":"22","author":"Barnes","year":"2003","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106451_bib0445","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/35094091","article-title":"Tobacco and the global lung cancer epidemic","volume":"1","author":"Proctor","year":"2001","journal-title":"Nature Reviews Cancer"},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106451_bib0450","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1073\/pnas.0409591102","article-title":"Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor","volume":"102","author":"Smith","year":"2005","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106451_bib0455","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbrc.2011.06.008","article-title":"The anti-inflammatory effects of soluble epoxide hydrolase inhibitors are independent of leukocyte recruitment","volume":"410","author":"Davis","year":"2011","journal-title":"Biochemical and biophysical research communications"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0460","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10753-016-0495-z","article-title":"Cigarette smoke-induced pulmonary inflammation and autophagy are attenuated in Ephx2-deficient mice","volume":"40","author":"Li","year":"2017","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106451_bib0465","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1007\/s13277-014-1689-3","article-title":"Interaction between smoking and CYP2C19* 3 polymorphism increased risk of lung cancer in a Chinese population","volume":"35","author":"Yan","year":"2014","journal-title":"Tumor Biology"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0470","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.plefa.2014.10.006","article-title":"Epoxyeicosatrienoic acids attenuate cigarette smoke extract-induced interleukin-8 production in bronchial epithelial cells","volume":"94","author":"Ma","year":"2015","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA)"},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106451_bib0475","doi-asserted-by":"crossref","first-page":"L970","DOI":"10.1152\/ajplung.00161.2016","article-title":"14, 15-Epoxyeicosatrienoic acid suppresses cigarette smoke condensate-induced inflammation in lung epithelial cells by inhibiting autophagy","volume":"311","author":"Li","year":"2016","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0480","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.taap.2011.12.009","article-title":"2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashion","volume":"259","author":"Bui","year":"2012","journal-title":"Toxicology and applied pharmacology"},{"issue":"8","key":"10.1016\/j.prostaglandins.2020.106451_bib0485","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3109\/00498254.2012.754113","article-title":"Acute arsenic treatment alters cytochrome P450 expression and arachidonic acid metabolism in lung, liver and kidney of C57Bl\/6 mice","volume":"43","author":"Anwar-Mohamed","year":"2013","journal-title":"Xenobiotica"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0490","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tox.2017.07.002","article-title":"Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38\/Smad3 pathways","volume":"389","author":"Dong","year":"2017","journal-title":"Toxicology"},{"issue":"12","key":"10.1016\/j.prostaglandins.2020.106451_bib0495","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0966-842X(97)82911-3","article-title":"Pseudomonas aeruginosa lipopolysaccharides and pathogenesis","volume":"4","author":"Goldberg","year":"1996","journal-title":"Trends in microbiology"},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106451_bib0500","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijmm.2007.03.012","article-title":"Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity","volume":"297","author":"Pier","year":"2007","journal-title":"International journal of medical microbiology"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0505","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.medmal.2005.10.007","article-title":"Targeting mechanisms of Pseudomonas aeruginosa pathogenesis","volume":"36","author":"Kipnis","year":"2006","journal-title":"Medecine et maladies infectieuses"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0510","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0022-3565(24)29560-4","article-title":"Cytochrome P450 metabolites of arachidonic acid but not cyclooxygenase-2 metabolites contribute to the pulmonary vascular hyporeactivity in rats with acute Pseudomonas pneumonia","volume":"297","author":"Yaghi","year":"2001","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106451_bib0515","doi-asserted-by":"crossref","first-page":"L1099","DOI":"10.1152\/ajplung.00039.2003","article-title":"Pulmonary cytochrome P450 2J4 (CYP2J4) is reduced in a rat model of acute Pseudomonas pneumonia","volume":"285","author":"Yaghi","year":"2003","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0520","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.prostaglandins.2012.09.003","article-title":"Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice","volume":"104","author":"Oni-Orisan","year":"2013","journal-title":"Prostaglandins & other lipid mediators"},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106451_bib0525","doi-asserted-by":"crossref","first-page":"L1213","DOI":"10.1152\/ajplung.00394.2016","article-title":"Soluble epoxide hydrolase deficiency or inhibition enhances murine hypoxic pulmonary vasoconstriction after lipopolysaccharide challenge","volume":"311","author":"Wepler","year":"2016","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"31","key":"10.1016\/j.prostaglandins.2020.106451_bib0530","doi-asserted-by":"crossref","first-page":"50958","DOI":"10.18632\/oncotarget.17331","article-title":"EETs reduces LPS-induced hyperpermeability by targeting GRP78 mediated Src activation and subsequent Rho\/ROCK signaling pathway","volume":"8","author":"Dong","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106451_bib0535","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12906-017-1747-7","article-title":"Attenuation of acute lung injury in a rat model by Semen Cassiae","volume":"17","author":"Chen","year":"2017","journal-title":"BMC complementary and alternative medicine"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106451_bib0540","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.1610242114","article-title":"Pseudomonas aeruginosa sabotages the generation of host proresolving lipid mediators","volume":"114","author":"Flitter","year":"2017","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"7","key":"10.1016\/j.prostaglandins.2020.106451_bib0545","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/metabo9070130","article-title":"Eicosanoid Profile of Influenza A Virus Infected Pigs","volume":"9","author":"Schultz","year":"2019","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0550","doi-asserted-by":"crossref","first-page":"H517","DOI":"10.1152\/ajpheart.00953.2005","article-title":"Protective effects of epoxyeicosatrienoic acids on human endothelial cells from the pulmonary and coronary vasculature","volume":"291","author":"Dhanasekaran","year":"2006","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0555","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1096\/fj.10-171488","article-title":"Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice","volume":"25","author":"Deng","year":"2011","journal-title":"The FASEB Journal"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0560","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1158\/0008-5472.CAN-13-1928","article-title":"PPAR\u03b1 Activation Can Help Prevent and Treat Non\u2013Small Cell Lung Cancer","volume":"74","author":"Skrypnyk","year":"2013","journal-title":"Cancer research"},{"issue":"3-4","key":"10.1016\/j.prostaglandins.2020.106451_bib0565","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10555-011-9315-y","article-title":"EET signaling in cancer","volume":"30","author":"Panigrahy","year":"2011","journal-title":"Cancer and Metastasis Reviews"},{"issue":"14","key":"10.1016\/j.prostaglandins.2020.106451_bib0570","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1158\/0008-5472.CAN-06-3643","article-title":"Cytochrome p450 epoxygenase promotes human cancer metastasis","volume":"67","author":"Jiang","year":"2007","journal-title":"Cancer research"},{"key":"10.1016\/j.prostaglandins.2020.106451_bib0575","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2014.01.045","article-title":"EETs alleviate ox-LDL-induced inflammation by inhibiting LOX-1 receptor expression in rat pulmonary arterial endothelial cells","volume":"727","author":"Jiang","year":"2014","journal-title":"European journal of pharmacology"},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106451_bib0580","doi-asserted-by":"crossref","first-page":"L664","DOI":"10.1152\/ajplung.00442.2015","article-title":"In vitro and in vivo evidence for an inflammatory role of the calcium channel TRPV4 in lung epithelium: Potential involvement in cystic fibrosis","volume":"311","author":"Henry","year":"2016","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106451_bib0585","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00441-015-2262-0","article-title":"Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"363","author":"Zhou","year":"2016","journal-title":"Cell and tissue research"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882320300447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882320300447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:01:48Z","timestamp":1761098508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882320300447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":117,"alternative-id":["S1098882320300447"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2020.106451","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of epoxyeicosatrienoic acids in the lung","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2020.106451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106451"}}